Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Rakovina Therapeutics Inc (RKV.VN)

Rakovina Therapeutics Inc (RKV.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Stocks in play: Rakovina Therapeutics Inc. Baystreet - Mon Apr 1, 9:03AM CDT

Will be hosting an informational webinar on Wednesday, April 3. Rakovina Therapeutics Inc. shares V.RKV ...

RKV.VN : 0.090 (unch)
Rakovina Therapeutics Announces Results from Annual General Meeting Globe Newswire - Thu Jun 23, 2022

VANCOUVER, British Columbia, June 23, 2022 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSXV: RKV) (the “Company”), a biopharmaceutical company...

RKV.VN : 0.090 (unch)
Rakovina Therapeutics Inc. Announces Q1 2022 Financial Results and Provides Corporate Update Globe Newswire - Thu May 26, 2022

VANCOUVER, British Columbia, May 26, 2022 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV, the “Company”), a biopharmaceutical company...

RKV.VN : 0.090 (unch)
Rakovina Therapeutics Inc. Announces 2021 Financial Results and Provides Corporate Update Globe Newswire - Wed Apr 27, 2022

VANCOUVER, British Columbia, April 27, 2022 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV, the “Company”) a biopharmaceutical company...

RKV.VN : 0.090 (unch)
InvestmentPitch Media Video Discusses Rakovina Therapeutics and its Presentation of Preclinical Data Supporting Potential Broad Anticancer Activity of kt-4000 Series at the American Association of Cancer Research Annual General Meeting Globe Newswire - Thu Apr 14, 2022

VANCOUVER, British Columbia, April 14, 2022 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSXV:RKV), a biopharmaceutical company committed to advancing...

RKV.VN : 0.090 (unch)
Rakovina Therapeutics Presents Preclinical Data Supporting Potential Broad Anticancer Activity of kt-4000 Series at the American Association of Cancer Research (AACR) Annual General Meeting Globe Newswire - Tue Apr 12, 2022

VANCOUVER, British Columbia, April 12, 2022 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (“the Company”), a biopharmaceutical company...

RKV.VN : 0.090 (unch)
Rakovina Therapeutics to Present Abstract at the 2022 AACR Special Conference – Sarcomas Globe Newswire - Wed Mar 30, 2022

Company will highlight new data with kt-3000 lead candidates as a potential treatment for Ewing sarcoma...

RKV.VN : 0.090 (unch)
Rakovina Therapeutics to Present Abstract at the 2022 Annual Meeting of the American Association of Cancer Research (AACR) Globe Newswire - Wed Mar 9, 2022

VANCOUVER, British Columbia, March 09, 2022 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (“the Company”), a biopharmaceutical company...

RKV.VN : 0.090 (unch)
Rakovina Therapeutics Inc. to Present at Biotech Showcase 2022 Globe Newswire - Thu Jan 6, 2022

VANCOUVER, British Columbia, Jan. 06, 2022 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSXV:RKV) (“the Company”), a biopharmaceutical company...

RKV.VN : 0.090 (unch)
Rakovina Therapeutics Announces Non-dilutive Financial Contributions to Support Lead Optimization of Novel Anti-cancer Agents Globe Newswire - Tue Dec 21, 2021

VANCOUVER, British Columbia, Dec. 21, 2021 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSXV: RKV) ("the Company"), a biopharmaceutical company...

RKV.VN : 0.090 (unch)

Barchart Exclusives

2 Standout Growth Stocks to Buy Now Barchart - 47 minutes ago
As technological advancements shape the advertising landscape, here are two growth stocks from the software space that investors might consider now. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot